REGENTS OF THE UNIVERSITY OF MINNESOTA;SHIRE HUMAN GENETIC THERAPIES INC.
发明人:
JOSIAH, Serene S,LUBY, Thomas M. TM,ASAKURA, Atsushi A,KEEFE, Dennis D,CHARNAS, Lawrence L,‧約西亞,‧盧比,‧朝倉,‧基夫,‧查納斯
申请号：
HK16101850.9
公开号：
HK1213918A
申请日:
2016.02.18
申请国别(地区):
HK
年份:
2016
代理人:
摘要：
The present invention provides, among other things, methods and compositions for treating muscular dystrophy, in particular, Duchenne muscular dystrophy (DMD). In some embodiments, a method according to the present invention includes administering to an individual who is suffering from or susceptible to DMD an effective amount of an anti-Flt-1 antibody, or antigen binding fragment thereof, such that at least one symptom or feature of DMD is reduced in intensity, severity, or frequency, or has delayed onset.
